US Stock MarketDetailed Quotes

VRDN Viridian Therapeutics

Watchlist

15.530
+0.240+1.57%

Close Feb 28 16:00 ET

15.530
0.0000.00%

Post 16:59 ET

1.26BMarket Cap-3.59P/E (TTM)

Viridian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Viridian Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 24.820K	--
--	2025/Q1	-- / 24.820K	--
--	2024/Q4	72.000K / 48.770K	--
--	2024/Q3	86.000K / 49.580K	--
--	2024/Q2	72.000K / 91.690K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 24.820K--

--2025/Q1-- / 24.820K--

--2024/Q472.000K / 48.770K--

--2024/Q386.000K / 49.580K--

--2024/Q272.000K / 91.690K--

Unlock Free Earnings Estimates

Open Account

Viridian Therapeutics Earnings Reports

Viridian Therapeutics | 8-K: Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 27 07:12 ET

Viridian Therapeutics | 8-K: Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data

Nov 12, 2024 09:31 ET

Viridian Therapeutics | 10-Q: Q3 2024 Earnings Report